CVS

CVS

USD

CVS Health Corporation Common Stock

$78.080-0.360 (-0.459%)

即時價格

Healthcare
Healthcare Plans
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$78.440

最高

$79.350

最低

$77.560

交易量

4.28M

公司基本面

市值

99.1B

行業

Healthcare Plans

國家

United States

交易統計

平均交易量

7.31M

交易所

NYQ

貨幣

USD

52週範圍

最低 $43.56當前 $78.080最高 $85.15

相關新聞

PR Newswire

CVS Health to hold Investor Day on December 9, 2025

CVS Health® (NYSE: CVS) will hold its Investor Day on December 9th, 2025. Members of management will discuss the Company's strategy and will provide...

查看更多
CVS Health to hold Investor Day on December 9, 2025
Analyst Upgrades

TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100

TD Cowen analyst Charles Rhyee maintains CVS Health with a Buy and raises the price target from $99 to $100.

查看更多
TD Cowen Maintains Buy on CVS Health, Raises Price Target to $100
Reuters

Obamacare premiums double, adding post Halloween fright for US health insurance shoppers

Americans shopping for 2026 Obamacare health insurance plans are facing a more than doubling of monthly premiums on average and are likely to postpone signing up in hopes of a last-minute reprieve, or walk away, health experts say.

查看更多
Obamacare premiums double, adding post Halloween fright for US health insurance shoppers
PR Newswire

CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity

CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is...

查看更多
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Analyst Upgrades

Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health with a Outperform and raises the price target from $85 to $95.

查看更多
Evercore ISI Group Maintains Outperform on CVS Health, Raises Price Target to $95
Analyst Upgrades

RBC Capital Maintains Outperform on CVS Health, Raises Price Target to $93

RBC Capital analyst Ben Hendrix maintains CVS Health with a Outperform and raises the price target from $81 to $93.

Analyst Upgrades

Cantor Fitzgerald Maintains Overweight on CVS Health, Raises Price Target to $95

Cantor Fitzgerald analyst Sarah James maintains CVS Health with a Overweight and raises the price target from $78 to $95.